NEW YORK — Mary Vaughan stands outside of the Brooklyn school where she first served as a poll worker. "This was my first assignment,” Vaughan said. “The reason why I kind of started doing it was, I ...

Having closed a nine-figure fundraising round, a newly launched biotechnology company hopes to rewire the immune system with drugs aimed at a special kind of nerve cell. Nilo Therapeutics debuted ...